Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 432, 118-122 (4 November 2004) | doi:10.1038/nature02993; Received 19 June 2004; Accepted 2 September 2004
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
nature jobs
Gastroenterologist
- South Atlanta Medical Clinic, PC (GI Group)
- Atlanta, GA, USA
Department Chair, Department of Human Science
- Georgetown University, Department of Human Science
- School of Nursing and Health Studies, 3700 Reservoir Rd. Washington, D.C. 20057
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase
Ralf Thoma1, Tanja Schulz-Gasch1, Brigitte D'Arcy1, Jörg Benz1, Johannes Aebi1, Henrietta Dehmlow1, Michael Hennig1, Martine Stihle1 & Armin Ruf1
- F. Hoffmann-La Roche AG, Pharma Research Discovery Chemistry, 4070 Basel, Switzerland
Correspondence to: Armin Ruf1 Email: armin.ruf@roche.com
The atomic coordinates have been deposited at the Protein Data Bank under the accession codes 1w6j (Ro 48-8071) and 1w6k (lanosterol).
Abstract
In higher organisms the formation of the steroid scaffold is catalysed exclusively by the membrane-bound oxidosqualene cyclase (OSC; lanosterol synthase). In a highly selective cyclization reaction OSC forms lanosterol with seven chiral centres starting from the linear substrate 2,3-oxidosqualene. Valuable data on the mechanism of the complex cyclization cascade have been collected during the past 50 years using suicide inhibitors, mutagenesis studies and homology modelling. Nevertheless it is still not fully understood how the enzyme catalyses the reaction1, 2. Because of the decisive role of OSC in cholesterol biosynthesis it represents a target for the discovery of novel anticholesteraemic drugs that could complement the widely used statins3. Here we present two crystal structures of the human membrane protein OSC: the target protein with an inhibitor that showed cholesterol lowering in vivo opens the way for the structure-based design of new OSC inhibitors. The complex with the reaction product lanosterol gives a clear picture of the way in which the enzyme achieves product specificity in this highly exothermic cyclization reaction.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Distribution of microbial terpenoid lipid cyclases in the global ocean metagenomeThe ISME Journal Original Article
Crystal structure of isopentenyl diphosphate:dimethylallyl diphosphate isomeraseThe EMBO Journal Article (02 Apr 2001)

